Welcome to Aptus Clinical
Specialist Clinical CRO
A full service Specialist Clinical CRO (Contract Research Organisation). As a result, we have a world class team of experts, with decades of industry experience in developing and delivering high quality clinical trials globally. Furthermore, we have a proven track record in optimising clinical development strategies through innovative trial design and execution. Our overall goal is to bring advanced and life-changing therapies to patients.
What makes Aptus Unique?
In short, Aptus offers a bespoke specialist clinical CRO solution. Focused on optimising project and resource management. This aims to offer efficient and effective trial development, conduct and delivery. Overall, our sharp commercial focus on the end goal adds value to every trial we design and manage.
Specialist in Oncology
Cell & Gene Therapy and Rare Disease
We are specialists in planning bespoke integrated, compliant clinical trials. As well as having long-established experience in delivering complex trials. Primarily, our focus is within rare diseases and oncology. Significantly within solid tumours, haematology, small molecules/ biologics and immuno-oncology. Additionally, we specialise in first time in human (FTiH) and phase Ib/II trials.
From Our Blog
Discover both recent news and media updates such as, case studies and white papers
Bespoke to you and only you
We offer a specialist clinical CRO solution our aim is to optimise project and resource management. This approach enables a particularly efficient and effective clinical trial development. Supporting from design and conduct to delivery. Another factor is our sharp commercial focus. Where we concentrate on the end goal adds value to every trial we design and manage.
World Leading Networks
Aptus are proud to hold long-standing collaborations with world-leading centres of excellence, because these centres provide access to large patient populations. Furthermore, such organisations promote innovation and collaboration across industry specialisms.